Member Info for Laura2022

Interesting that despite a revenue drop today One peer still beig valued at x 10 annual revenues while PYC only c 1.5

Got to change soon :)

Recommendation

The Board considers the approval of the Resolutions being proposed at this GM to be in the best interests of the Company and its Shareholders as a whole and, accordingly, unanimously recommends that Shareholders vote in favour of the Resolutions.

Premier has limited funds and must secure additional financing arrangements to meet its payment commitments and obligations as they fall due. Shareholders should be aware that, if Resolutions 1 and 2 are not passed at the GM, the Company would need to pursue alternative funding options, which may include a discounted open offer to Shareholders. There can be no assurance that such an open offer would be fully taken up or that other funding arrangements could be secured within the required timeframe and on acceptable terms. Failure to do so could have a material adverse effect on both Zulu Lithium and the financial position of the Company as a whole.

As previously reported, should the Com

Starting to feel very very overdone

Huge buy

21 mln volume now

Looks like 0 27 will go soon

Solstace

That's exactly what was mentioned in thr interview

Ukog are critical to plans of

RWS, National Gas, SSE , etc

Wakey, TH2,MAark

My pleasure

I would imagine more gamw changing news now that UKOG met with UK GOV 23rd Sept

LOI or MOU

With

Sumitomo (japan) , RWS and SGN

He said earlier int3rview that while NatGas was a giant and UKOG a minnow their is co-reliance , particularly now UK gov in last 3 weeks has been far clearer on timelines and funding

The larger companies need to connect Teesside, Yorkshire and South Coast, and UKOG are important in this

Talking to regional players in Dorset ( from bottom up)

No

The shenanigans continue semantic

semantic

Posted in: IBAI

Posts: 278

Price: 1.00

No Opinion

RE: Looking positive.9 Oct 2025 11:27

Paladin (and others here), surely the 50m shares traded over recent days (and 14m traded over three days last month) dispel finally the myth that people stay away from IB because of the 'shenanigans' of TEB?

Maybe this will allow space for more intelligent and productive discussion to take place

Laughable smoke screen

Trevor Brown recused himself from all deliberations concerning the SPA and CLN, ensuring robust governance and full compliance with applicable regulatory standards. These steps reflect the Company's ongoing commitment to transparent corporate governance and robust Shareholder protections

A first-of-a-kind project which would unite hydrogen production, storage and power generation in one location has been shortlisted by UK Government in a recent funding process.

Located at SSE Thermal and Equinor’s existing Aldbrough Gas Storage facility in East Yorkshire, Aldbrough Hydrogen Pathfinder will support the evidence base for wider deployment of flexible hydrogen power in the UK by providing a meaningful-scale demonstration of the interactions between hydrogen electrolysis, hydrogen cavern storage and 100% hydrogen dispatchable power.

The concept would see clean power sourced from grid in compliance with the Low Carbon Hydrogen Standard. Hydrogen would then be produced via a 35MWe electrolyser before being stored in a converted salt cavern and then used in an open cycle gas turbine operating on up to 100% hydrogen, exporting flexible green power back to grid at times of system need.

Aldbrough Hydrogen Pathfinder is significantly advanced as a project, with front end engineering and design completed and a planning application currently under review. The project could be operational by 2029, subject to positive planning and final investment decision. As such, it is the only realistic option to introduce hydrogen to power onto the system ahead of the Government’s 2030 target for a clean power system.

SSE Thermal and Equinor will now enter into a due diligence phase with the Department for Energy Security and Net Zero as part of its ‘Hydrogen Allocation Round 2’ funding process.

Https://www.sse.com/our-technologies/hydrogen/

Next potential JV/MOU?

SSE ??

East Yorkshire Hydrogen Storage (UKEn 100%)

The Company is planning a further hydrogen storage project in East Yorkshire, located nearby to the existing SSE Thermal/Equinor Aldbrough gas storage site.

Regulatory guidance on the use of MIDDRegulatory bodies and international organisations see the valueof MIDD in evidence-based drug development to enhancedecision-making and risk mitigation, and improve patientoutcomes – whether it be providing rationale for trial design,optimised dosing or prediction of drug safety. A high-profleexample of this is the FDA Project Optimus initiative – aimed tooptimise drug dosing in oncology – which encourages the useof PopPK and exposure-response modelling to analyse clinicaldata and semi-mechanistic or mechanistic modelling to supportdose selection.6Another example is a recent call for reducinganimal studies in monoclonal antibody drug development andreplacement with new approach methodologies, includingin silicoapproaches.The FDA MIDD Program builds on a pilot programme, whichwas established in 2018 to facilitate the use of MIDD in drugdevelopment workfows.7The programme provides a platformfor researchers, both mathematical and experimentalists, todiscuss MIDD approaches and share advice on best practices forintegration. Through interdisciplinary discussions, the FDA-ledprogramme is both promoting the implementation of mathematicalapproaches and improving the quality of models used indrug development.

MDD "entering a golden age "

By Mark Davies and Hayley Close at PhysiomicsThe pharmaceutical industry is under increasing pressurefrom healthcare providers and regulatory agencies alike todevelop novel effective therapeutics quicker and at lower cost.The use of computational approaches across drug discoveryand development (DD&D) offers the opportunity for addressingthese challenges, with established areas such as modellingand simulation, often referred to as model-informed drugdevelopment (MIDD), entering a golden age.Mathematical modelling and simulation to supportdrug developmentThe feld of MIDD refers to the strategic design and integrationof mathematical models into DD&D workfows to facilitatedecision-making, from target ID and candidate design/selection,to preclinical and clinical research, including insights for doseselection and optimisation.Many of the models that make up MIDD are based onpharmacokinetic-pharmacodynamic (PK/PD) modelling, amathematical approach to studying the relationship betweenthe two components, connecting drug dose to physiologicalresponse.1This breaks down as what the body does to thedrug (ie, pharmacokinetics) and what the drug does to thebody (ie, pharmacodynamics), including elements of toxicity andadverse effects.Building on these techniques, population pharmacokinetic(PopPK) models are designed to study the pharmacokinetics at

Great end to the day

Now 0.27p for 80mln

0.0267 (well above ask) f0r 70mln

Have made 100% on half sale of HE1 bought in summer

Have put those prof9ts here to go to 70mln UKOG shares under 0.03p average